Stem Point Capital LP Xenon Pharmaceuticals Inc. Transaction History
Stem Point Capital LP
- $314 Billion
- Q1 2025
A detailed history of Stem Point Capital LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 274,633 shares of XENE stock, worth $9.18 Million. This represents 2.94% of its overall portfolio holdings.
Number of Shares
274,633
Previous 375,845
26.93%
Holding current value
$9.18 Million
Previous $14.7 Billion
37.46%
% of portfolio
2.94%
Previous 3.68%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
224Shares Held
71.1MCall Options Held
435KPut Options Held
207K-
Avoro Capital Advisors LLC New York, NY5.74MShares$192 Million3.12% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.58MShares$153 Million1.68% of portfolio
-
Wellington Management Group LLP Boston, MA3.79MShares$127 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$111 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.09MShares$103 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.08B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...